Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma?

참고문헌 (11)

1. Harris NL, "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues : report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997", J Clin Oncol, 17, pp.3835~3849 (1999)
2. Sehn LH, "Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia", J Clin Oncol, 23, pp.5027~5033 (2005)
3. Cheson BD, "Monoclonal antibody therapy for B-cell non-Hodgkin’s lymphoma", N Engl J Med, 359, pp.613~626 (2008)
4. Winkler U, "Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody(rituximab, IDEC-C2B8)", Blood, 94, pp.2217~2224 (1999)
5. Byrd JC, "Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells : association with increased infusion-related side effects and rapid blood tumor clearance", J Clin Oncol, 17, pp.791~795 (1999)
6. Hong J, "Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma", Support Care Cancer, 21, pp.1145~1152 (2013)
7. Schwartzberg LS, "Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice : results of a multicenter study", Support Care Cancer, 17, pp.91~98 (2009)
8. Giovannini M, "Clinical significance of skin toxicity due to EGFR-targeted therapies", J Oncol, 2009, pp.849051~ (2009)
9. Lenz HJ, "Management and preparedness for infusion and hypersensitivity reactions", Oncologist, 12, pp.601~609 (2007)
10. 조경민, "Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP", The Korean Journal of Internal Medicine, 34(4), pp.885~893 (2019), 대한내과학회[DOI]
11. van der Kolk LE, "Complement activation plays a key role in the side-effects of rituximab treatment", Br J Haematol, 115, pp.807~811 (2001)

관련 논문AI추천